Prodromal Alzheimer's disease is a novel area of research, with clinical research definitions still under development. The LipiDiDiet trial,¹ published in The Lancet Neurology, was one of the first completed trials based on the International Working Group (IWG-1) criteria for prodromal Alzheimer's disease.² The study was a non-pharmacological intervention (medical food Souvenaid) in prodromal Alzheimer's disease.

中文翻译：

---

针对前驱性阿尔茨海默氏病：预防为时已晚？

前驱性阿尔茨海默氏病是一个新兴的研究领域，临床研究定义仍在发展中。该LipiDiDiet试验，¹发表于柳叶刀神经病学，是基于国际工作组（IWG-1）的前驱性阿尔茨海默氏病的标准首先完成的试验之一。²该研究是对前驱性阿尔茨海默氏病的非药物干预（医学食品Souvenaid）。